Skip to main content

Table 1 Medications of interest in the study

From: Follow-up after surgical treatment for intermittent claudication (FASTIC): a study protocol for a multicentre randomised controlled clinical trial

Medication group ATC Code
Antithrombotic agents
 Vitamin K antagonists B01AA
 Heparin group B01AB
 Platelet aggregation inhibitors excluding heparin B01AC
 Direct thrombin inhibitors B01AE
 Direct factor Xa inhibitors B01AF
Lipid-modifying agents
 HMG CoA reductase inhibitors C10AA
 Fibrates C10AB
 Other lipid-modifying agents C10AX
Antihypertensives
 Diuretics C03
 Beta-blocking agents C07
 Calcium channel blockers C08
 ACE inhibitors, plain C09A
 ACE inhibitors, combinations C09B
 Angiotensin II antagonists, plain C09C
 Angiotensin II antagonists, combinations C09D
  1. legend: Medications of interest in the study and their Anatomical Therapeutic Chemical (ATC) codes according to the WHO Collaborating Centre for Drug Statistics Methodology (WHOCC) classification.
\